Invalid Symbol

Stock Research for TTHI

TTHI
Current Price

$


Latest Update:

High
$
Low
$
Close
$
Volume
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

TTHI Stock Chart & Research Data

The TTHI chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the TTHI chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


TTHI Due diligence Resources & Stock Charts

The TTHI stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View TTHI Detailed Price Forecast - CNN Money CNN View TTHI Detailed Summary - Google Finance
Yahoo View TTHI Detailed Summary - Yahoo! Finance Zacks View TTHI Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View TTHI Trends & Analysis - Trade-Ideas Barrons View TTHI Major Holders - Barrons
NASDAQ View TTHI Call Transcripts - NASDAQ Seeking View TTHI Breaking News & Analysis - Seeking Alpha
Spotlight View TTHI Annual Report - CompanySpotlight.com OTC Report View TTHI OTC Short Report - OTCShortReport.com
TradeKing View TTHI Fundamentals - TradeKing Charts View TTHI SEC Filings - Bar Chart
WSJ View Historical Prices for TTHI - The WSJ Morningstar View Performance/Total Return for TTHI - Morningstar
MarketWatch View the Analyst Estimates for TTHI - MarketWatch CNBC View the Earnings History for TTHI - CNBC
StockMarketWatch View the TTHI Earnings - StockMarketWatch MacroAxis View TTHI Buy or Sell Recommendations - MacroAxis
Bullish View the TTHI Bullish Patterns - American Bulls Short Pains View TTHI Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View TTHI Stock Mentions - StockTwits PennyStocks View TTHI Stock Mentions - PennyStockTweets
Twitter View TTHI Stock Mentions - Twitter Invest Hub View TTHI Investment Forum News - Investor Hub
Yahoo View TTHI Stock Mentions - Yahoo! Message Board Seeking Alpha View TTHI Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for TTHI - SECform4.com Insider Cow View Insider Transactions for TTHI - Insider Cow
CNBC View TTHI Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for TTHI - OTC Markets
Yahoo View Insider Transactions for TTHI - Yahoo! Finance NASDAQ View Institutional Holdings for TTHI - NASDAQ


Stock Charts

FinViz View TTHI Stock Insight & Charts - FinViz.com StockCharts View TTHI Investment Charts - StockCharts.com
BarChart View TTHI Stock Overview & Charts - BarChart Trading View View TTHI User Generated Charts - Trading View


Latest Financial News for TTHI


Posted on Wednesday December 31, 1969



Posted on Wednesday December 31, 1969



Posted on Wednesday December 31, 1969



Posted on Wednesday December 31, 1969


Critical Analysis: Transition Therapeutics (TTHI) and VIVUS (VVUS)
Dispatch Tribunal - 12 hours ago
Transition Therapeutics logo Transition Therapeutics Inc. is a product-focused biopharmaceutical company. The Company's principal business activity is the researching and developing of therapeutic agents.

Head to Head Comparison: Fortress Biotech (NASDAQ:FBIO) versus Transition ...
The Ledger Gazette - Feb 12, 2018
Transition Therapeutics logo Transition Therapeutics Inc. is a product-focused biopharmaceutical company. The Company's principal business activity is the researching and developing of therapeutic agents.

Analyzing Transition Therapeutics (TTHI) and VIVUS (VVUS)
The Lincolnian Online - Feb 15, 2018
Transition Therapeutics Inc. is a product-focused biopharmaceutical company. The Company's principal business activity is the researching and developing of therapeutic agents.

CRISPR Therapeutics Announces Transition of Bill Lundberg, MD
GlobeNewswire (press release) - Feb 8, 2018
“I have had the privilege of working with a wonderful, talented and dedicated group of people at CRISPR Therapeutics,” said Dr.

Enter a stock symbol to view the stock details.